Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3722_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
30 Мб
Скачать
258
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Occlusion rate
at 1-year (or
greater)
93–97% [28,
• Cutaneous (soreness,
29]
bruising, tenderness, and
induration)
• Supercial phlebitis
• Thermal: nerve injury and
94% [30]
skin burns (rare)
• DVT (rare)
• Cutaneous (soreness,
bruising, tenderness, and
induration)
• Supercial phlebitis
• Thermal: nerve injury and
skin burns (rare)
• DVT (rare)
S. S. Ahmed et al.
Cost
data
• Robust long-term
SFJ beyond the supercial epigastric
vein
80–100J/cm of energy deposition
• Pull back at a rate for a goal of
• Thigh-high compression stockings
data
• Robust long-term
SFJ
(30–40mmHg) are typically used
• Position catheter tip 2cm from the
• Pullback 7cm for the rst cycle
remainder of the vein
pullback for a “double cycle”
• Advance catheter and repeat 7cm
• Pullback 6.5cm/cycle for the
(30–40mmHg) are typically used
• Thigh-high compression stockings
thrombosis
[25,
26] Mechanism Technique (for GSV) [27] Advantages Complications [20, 2224]
$$ Heat-induced
Technique
Thermal
Table 7.4 Comparison of thermal axial ablation therapy, non-thermal axial ablation therapy, and ultrasound-guided foam sclerotherapy in treatment of the GSV
Laser $$ Heat transfer • Position catheter tip 2cm from the
Radiofrequency
(ClosureFAST)
7 Venous Interventions
Occlusion rate
at 1-year (or
greater)
97% [31]
259
94% [32]
73% [33]
72% [34]
ecchymosis)
• Cutaneous (pain and
• Supercial phlebitis
• Allergic reaction
compression not
required
• Post-procedure
from the SFJ
• Position catheter tip 5cm peripheral
anesthesia
• No tumescent
US probe
dose
dose
rst dose
• Manually compress centrally with
• Push trigger for 3s to deliver rst
• Pull back 1cm and apply a second
• Compress treated vein for 3min after
dose and compress for 30s
• Subsequently pull back every 3cm/
ecchymosis)
• Cutaneous (induration and
• Supercial phlebitis
anesthesia
• No tumescent
• Dual modality
to the SFJ
• Position catheter tip 1cm peripheral
simultaneously injecting sclerosant
and pulling back at a rate of
for 2–10s to induce venospasm
• Activate wire rotation at ~3500rpm
• Engage motor trigger while
1.5mm/s every 3s
• Pain
• Supercial phlebitis
anesthesia
• No tumescent
for 2weeks
• Thigh-high compression stockings
• Detach canisters and attach syringe
• DVT
determined
concentration
• Fixed pre-
to transfer unit at the top of the
perforators
• Fills incompetent
polidocanol canister and waste 3mL
maximum of 15mL
• Elevate leg 45°
• Inject in aliquots of 5mL for
microfoam reaches SFJ
• Apply pressure at GSV once
• Hyperpigmentation
• No tumescent
for 2weeks
• Thigh-high compression stockings
• Ulceration
• Matting
anesthesia
• Inexpensive
in a preferred ratio
2
room air or CO
dependent on vessel size
to under 10mL per session
• Inject in aliquots of 3–5mL limiting
Cost
[25,
26] Mechanism Technique (for GSV) [27] Advantages Complications [20, 2224]
Technique
blood
$$$ Polymerization with
Non-thermal
Cyanoacrylate glue
(VenaSeal)
wire and chemical
detergent
$$$ Mechanical rotating
Mechanochemical
(ClariVein)
$$$ Detergent • Attach canisters to generate foam
Polidocanol
(Varithena)
$ Detergent • Mix 1–1.5% STS or 2–3% POL with
Ultrasound-guided
foam sclerotherapy
Cost: $=<$500, $$=500–1000, $$$>1000in U.S. dollars.
260
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 7.4 Ultrasound images demonstrate a dilated perforator vein in the thigh (Arrow) and reux for greater than 0.5s
S. S. Ahmed et al.
UGFS.It is important that patients be aware prior to treatment.
• Extravasation of sclerosant is the most feared complication of UGFS and can result in ulceration secondary to tissue necrosis. Treatment consists of local wound care.
Peri-Ulcer Varices Management
It is not uncommon to nd that there are patients with VLU and venous insufciency by examination, however, noninvasive studies are inconclusive or disgruent. In these patients, it is prudent to perform a more detailed direct ultrasound evaluation of the wound area, which may demonstrate varices around and coursing from the ulcer. In these situations, percutaneous foam sclerotherapy of these varices under ultrasound (can be combined with uoroscopy to ensure no deep vein reux) guidance. In doing this, it is possible to accelerate VLU healing.
Case Example
Courtesy of Sreekumar Madassery, MD
A 72-year-old female with long-term wound
care management of bilateral painful VLUs, despite compressive therapy, arterial evaluation, wound care including skin substitutes and other conserva­tive approaches. After percutaneous sclerotherapy of peri-ulcer varices, there was rapid VLU healing with eventual wound closure (Fig.7.5).
Conclusion
A thorough understanding of the pathophysiol­ogy of supercial venous disease that results in venous hypertension and VLU is essential. Prompt evaluation, diagnosis, and endovenous intervention can improve the time to ulcer healing and prevent signicant morbidity. The optimal treatment should be directed at the intended source of venous hypertension, which can be mixed between supercial venous reux and deep vein obstruction. While early endove­nous intervention is benecial in shortening healing time, it is important to remember that recurrent ulceration is common and continued follow-up of patients with prior VLU is important.
Finally, it should be noted that superficial venous closure has grown in abundance over the years, often for cosmetic reasons, as well as for symptomatic grounds. This is a vital conduit for other vascular beds in patients such as those with CAD and PAD, thus it should be considered with some caution in all comers. For patients with VLU, many opera­tors will choose to intervene on patients that have significant varicosities in the venous dis­tribution of the wound and those that demon­strate peri-wound varices, as these anecdotally can have a greater healing result, compared to patients with less obvious reflux- related sequelae.
and insignificant areas of GSV and SSV reflux.
below the knee.
7 Venous Interventions
261
Long standing (>1 year) LLE distal leg and ankle venous non healing ulcers despite wound care, compression therapy, skin substitutes, and attempts at increased ambulation. Noninvasive venous studies showed relatively small caliber
Fig. 7.5 Case example of nonhealing VLU that improved after endovenous intervention
7.3 Deep Venous Disease
Direct percutaneous sclerotherapy of abnormal peri-ulcer varices, with tourniquet applied just
sections, it is estimated that billions of dollars are
2 months after embolization and continued wound care, rapid VLU healing was noted, with eventual wound closure as well as pain relief.
spent each year on venous leg ulcers worldwide
BrianP.Holly and MarkLessne
with direct medical costs per patient averaging over $5000 (USD) per year [20]. Therefore, preventing ulcer formation is the main goal of treatment. This section will review indications
7.3.1 Introduction
for deep venous disease treatment, including stent placement and techniques to maximize
Deep venous disease can be categorized as acute,
patient safety and efcacy.
subacute, or chronic with symptoms resulting from deep venous reux or obstruction. The exact categorization of the chronicity may be difcult, however, many consider >4weeks into the chronic phase. Acute venous disease rarely leads to limb loss outside of phlegmasia cerulea dolens, which is an extensive, occlusive venous thrombosis leading to venous gangrene in 40–60% of patients [18, 19]. Even chronic deep venous disease resulting from venous stenosis/ occlusion or from compression syndromes rarely results in limb loss. Causes of obstruction or compression may include occlusion from thrombosis, compression from a mass, post­thrombotic syndrome, or non-thrombotic causes. However, venous leg ulcers account for 70% of all chronic leg ulcers and are associated with high recurrence rates. As discussed in previous
7.3.1.1 When toTreat Deep Veins
The presence of deep venous disease is not, by itself, an indication for treatment as many patients with deep venous reux, venous stenosis, or compression may be entirely asymptomatic depending on the anatomic distribution, compensatory collateralization, and patient condition. For example, seemingly signicant (>50%) left common iliac vein compression can be found not uncommonly in healthy subjects or those without lower extremity symptoms [21
23]. Therefore, conrmation of clinically
signicant and correlative signs and symptoms of deep venous disease is mandatory prior to intervention. The previously mentioned classication systems are available to assist with this assessment.
262
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
S. S. Ahmed et al.
In patients with deep vein obstruction, post­thrombotic syndrome (PTS) develops in 20–50% of patients and presents as lower extremity swell­ing, abdominal fullness or bloating (in the setting of IVC occlusion), lower extremity heaviness, fatigue, and/or paresthesias.
• Venous stasis changes are also seen including
lipodermatosclerosis, skin bronzing, dilated
varicose, spider, or reticular veins, and in
severe cases, ulcerations [24].
Many signs and symptoms of supercial venous disease may overlap with those of deep venous disease. It is an important principle that when patients’ symptoms can be ameliorated by treating the supercial venous reux alone, this should be pursued rst and exclusively.
• Treatment of deep venous disease, almost
always requires implantation of a permanent
stent in the iliac veins and should be reserved
for those patients in whom symptoms are pre-
dominately related to deep venous obstruction.
• Additionally, while conservative management
is often the rst-line therapy for mild venous
disease—including weight loss, exercise,
lower extremity compression, and leg
elevation—for patients with venous ulcers
related to deep vein disease, a trial of
conservative management is not always
required and more aggressive interventional
therapies early on may be warranted.
• Early endovenous treatment has been shown
benecial for supercial venous disease and
likely holds true for symptomatic deep venous
disease in the setting of severe symptoms, as
well [5]. Medical management can and should,
however, still be offered concurrently with inter-
vention for venous stasis ulcers: aside from
wound care and compression, pentoxifylline has
been found to be a more effective therapy for
venous wounds than compression alone [25].
• Primary patency for iliac vein stenting in non-
thrombotic disease is reported to be 90%—
100% and 74%–89% in post-thrombotic
disease [26].
• Additional indications for recanalization or reconstruction include deep vein occlusion secondary to recurrent DVT, post-thrombotic syndrome, and thrombosis of the IVC, all leading to lifestyle limitations.
• Surgical treatments are rarely utilized and reserved for cases refractory to stenting.
7.3.1.2 Work-Up
A thorough history and physical are essential to the diagnosis, and should evaluate for:
• Signs and Symptoms of venous obstruction.
• Prior vascular interventions (including venous catheterizations as a neonate and child), history of surgery, infections, and/or radiotherapy that may have compromised the deep venous system.
• Personal and family history of VTE and rele­vant details (anatomic location, recurrence, provoking factors, genetic disorders).
Typically, some imaging is performed for
patients with clinical suspicion of deep venous disease.
• Duplex ultrasound to evaluate the supercial and deep venous system is almost always the rst imaging test.
• Depending on the patient’s body habitus and skill set of the sonographer, ultrasound can be very useful to depict iliac vein compressions and even IVC patency.
– Even when the pelvic veins cannot be
imaged, deep venous reux or loss of pha­sicity and augmentation in the common femoral vein may be indirect signs of iliac vein or caval obstruction and may warrant cross-sectional or catheter-based venogra­phy and intravascular ultrasound for fur­ther evaluation.
• Lab work for systemic causes of lower extrem­ity swelling should also be considered in the appropriate clinical context.
• Etiologies with the suspicion of inferior vena cava or iliac vein involvement are typically diagnosed via CT or MRI.
7 Venous Interventions
263
Iliac Vein Compression
Acute or chronic deep vein thrombosis (DVT) of the inferior vena cava (IVC) and iliac veins, other­wise known as iliocaval thrombosis, can lead to lower extremity edema, pain, and other limb­threatening occlusive symptoms. Iliocaval throm­bectomy, recanalization, and/or reconstruction (i.e., angioplasty/stenting) are accepted treatment options in management of this disease.
Non-thrombotic iliac vein lesions (NIVL) may lead to May-Thürner disease commonly caused by an obstructive anatomical variant that can lead to occlusion of the left iliac vein due to compression from the right iliac artery as it crosses over the vein. Some other causes include compression by a pelvic mass (tumor, broids, etc.), pregnancy, or retroperitoneal brosis. Initial diagnosis requires evaluation for DVT. Once DVT has been ruled out, then further work-up for May-Thurner syndrome (MTS) includes imaging evidence to suggest compression.
Imaging Findings Suggestive ofIliac Vein Compression
• Duplex ultrasound—sluggish venous outow,
venous reux, poor
• augmentation.
• CT/MR Venography—Generally very sensi-
tive and specic (>95%) for diagnosing iliac
vein compression [27].
• Catheter venography—Filling defects, com-
pression was seen in multiple projections,
transvenous (hemodynamic) pressure
measurements.
• Intravascular Ultrasound (IVUS)—Now con-
sidered by many to be the gold standard to
diagnose iliac vein compression with
improved sensitivity and specicity relative to
catheter venography alone [28]. IVUS can
accurately measure normal vessel diameter,
percent stenosis, identify exact location of ste-
nosis, and aid in planning stent placement.
Treatment (When toStent)
• Stent placement is an established treatment
for symptomatic NIVL with excellent long-
term patency. Stent placement should be
considered for symptomatic patients with venographic and IVUS ndings demonstrating a signicant ow-limiting stenosis.
• Thrombolysis can be used if necessary.
• Stent diameter should be sized according to the diameter of the normal vessel adjacent to the stenotic segment. The stent must cover the stenosis entirely.
Figure 7.6 demonstrates left common iliac vein
compression by the overlying right common iliac artery, ndings are consistent with non- thrombotic MTS.Figure7.7 demonstrates restored ow of the left common iliac vein via stent placement.
Case courtesy of Osman Ahmed, MD
Iliac Vein Occlusion
Iliac vein occlusion (ILVO) most often is the result of an iliac vein thrombus that failed to adequately recanalize. Patients presenting with ILVO often have similar symptoms to those with iliac vein compression, however, symptoms are often worse. Post-thrombotic syndrome (PTS) in these patients can be severe and debilitating.
Treatment (When toStent)
• Any patient with an ILVO, in whom the occlu­sion can be crossed with a wire, will require stent placement.
• Stent should be sized according to the closest segment of patent/healthy vein. The stent must have good venous inow and extend into an open outow vein.
Stent Placement Below theInguinal Ligament
In the case of ILVO, often the diseased segment of vein extends below the inguinal ligament.
• It is mandatory to stent from healthy vein to healthy vein, as this gives the stented portion of the vein the best chance of maintaining long-term patency, by creating good inow and outow. This may also require extending the stent below the inguinal ligament into the femoral vein.
– Stenting below the inguinal ligament has
been considered controversial as some
264
ab
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
S. S. Ahmed et al.
c
Fig. 7.6 Pre-intervention contrast CT pelvis (a), intra- vascular ultrasound (b), and venogram (c), all demon­strate compression of the iliac vein by the overlying right
Fig. 7.7 Post-stent placement intravascular ultrasound (a) and uoroscopy X-ray (b) demonstrate restored ow of the left common iliac vein. Coils can also be noted in Fig.7.2b as gonadal vein embolization was concurrently for pelvic congestion
a b
common iliac artery. These ndings are compatible with non-thrombotic May-Thurner syndrome
report decreased patency rates when extending the stent below the inguinal ligament. However, more recent reports demonstrate similar patency rates and rates of clinical improvement when extending the stent below the inguinal ligament if required to cover all diseased segments [29].
Tips andTricks
Note: It is expected that the interventionalist caring for the patient with deep vein disease possesses basic and fundamental skills in endo­vascular techniques including catheter and wire crossing, stent deployment, radiation safety, as well as mitigation of and therapy for complica­tions. A list of “tips and tricks” cannot replace
7 Venous Interventions
265
formal and proper training through an accred­ited interventional/endovascular program.
IVC andIliofemoral Occlusions
Since all deep venous disease must start and end with a healthy vessel to establish normal inow and normal outow, the segments of diseased veins must be carefully delineated prior to inter­vention in order to guide appropriate access.
• Avoid accessing a vein that will limit the abil­ity to treat the entire segment of diseased vein. Common femoral vein access may be appro­priate for isolated iliac vein or IVC obstruc­tion but may hinder treatment of disease extending to distal external iliac and common femoral vein.
– In this case, a mid-femoral vein, popliteal
vein, or greater saphenous vein access may be preferred.
• As discussed above, it is mandatory for stents to bridge from normal vessel to normal vessel. Iliofemoral stents may be placed down to but ideally never beyond the lesser trochanter.
– It is critical to maximize inow into the
stent by ensuring adequate ow is present from the deep femoral and/or femoral veins.
Equipment
• Micropuncture or single wall needle for access.
• Guidewires:
– Crossing Wires: 0.035 and 0.018 stiff
hydrophilic wires and weighted wires (30g tip load).
– Working wires: Super stiff Amplatz wire.
• Sheath: 8 or 9 Fr sheath (to allow for IVUS catheter and venous stents, respectively), 7 Fr MPA guide catheter for extra support; Alternatively, prefabricated support systems such as Triforce (Cook, Bloomington IN).
• Catheters: Angled diagnostic or support catheters.
• Balloons: Noncompliant, high-pressure balloons.
• Stents: Dedicated venous stents; Wallstents or Z-stents (less commonly); covered stents available for bailout in case of complications.
• Intravascular Ultrasound: 0.035 compatible IVUS catheters.
• Niche devices: Trans-septal needle, Chiba needle, RF Power Wire, snares.
Venous Recanalization Procedure Steps
1. Access site selection: Internal/external jugu-
lar, brachial/basilic, common femoral, femo­ral, popliteal, and posterior tibial veins are all viable access options.
2. Robust support, such as triaxial system with
sheath, guide catheter, and crossing catheter is mandatory. The system should be placed close to the occlusion (“take the ght to the sight”). Attempt crossing using glidewire and support catheter. Rotate the wire while apply­ing minimal forward pressure in an Archimedes screw type fashion clockwise and then counterclockwise—do not let wire prolapse into a J shape.
Tip: For chronic total occlusions, keep catheter closely behind tip of wire and cross incrementally, advancing catheter to wire tip, millimeter by millimeter if necessary.
3. Once successfully crossed, repeat venogram to conrm expected, intraluminal position.
Tip: Can further conrm with lateral view and cone beam CT (ideal), as there can be inadvertent spinal canal crossing if not cautious.
4. Place stiff working wire, such as Amplatz wire.
5. Intravascular ultrasound (IVUS) has been shown to be more sensitive in detecting stenotic lesions compared to venography and is critical to aid with proper vessel sizing, conrmation of stent expansion, and evaluation of residual disease.
(a) IVUS is used complimentary with venog-
raphy, which demonstrates hemodynamic obstruction, such as lling of venous col­laterals or poor contrast washout.
266
ab
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
S. S. Ahmed et al.
Tip: With IVUS in a suspected com­pressive lesion, leave the IVUS catheter at the site over multiple respiratory cycles to conrm the lesion is xed and not a “pseudo stenosis,” that should not be treated (Fig.7.8). Patient leg positioning can also x pseudo stenotic lesions.
6. Angioplasty and/or stent according to clinical scenario (see tips above).
Tip: While IVUS and venography are essential tools for optimal stent position­ing, bony landmarks can also be used, including the right vertebral pedicle and spinous process for left iliac vein stent placement [30].
Stenting theILIAC Venous Conuence
There are four main techniques employed when stent reconstruction of the bilateral iliac veins and iliac venous conuence is required (Fig.7.9):
1. Double barrel: Self-expanding stents are placed extending from the IVC into the iliac veins in parallel fashion.
2. Fenestrated Inverted Y: A single stent is placed extending from the IVC to one of the iliac veins, jailing the contralateral iliac vein. The interstices of that stent are then crossed from the contralateral side and dilated,
allowing for placement of another stent through the dilated interstice and into the contralateral iliac vein.
3. T-stent: A single stent is placed extending from the IVC to one of the iliac veins, jailing the contralateral iliac vein. A second stent is placed in the contralateral iliac vein up to and abutting the rst stent, but not crossing into it.
4. Coaxial IVC-double barrel: A single, large stent is placed in the IVC, followed by parallel stents placed into the IVC stent and extending into the iliac veins.
In general, fenestrated inverted Y and T-stent techniques are strongly discouraged and there is data to support that these techniques lead to worse patency [31]. The fenestrated inverted Y technique, however, is the only option when presented with a patient who requires iliac vein stent placement on a side jailed by a previously placed iliocaval venous stent (Fig.7.10).
Complications
1. Failure: The most common “complication” of
recanalization procedures is the inability to cross the lesion. If this occurs, consider alternative access, obliquities, techniques, or imaging to delineate the geometry of the
Fig. 7.8 (a) Initial IVUS image demonstrates venous stenosis. (b) Later in the respiratory cycle the stenosis is shown to be a normal, well-expanded vein, not a xed lesion (“pseudo stenosis”)
7 Venous Interventions
267
Fig. 7.9 Techniques of Iliac Conuence Stent Placement: (a) Double Barrel—two stents have been placed parallel from the iliac veins to the IVC (b) T stent­Right iliac vein stent abuts a left iliocaval venous stent (this is strongly discouraged) (c) Coaxial—a large IVC stent is placed, and (d) two double barrel stents have been placed coaxial from the iliac veins into the IVC stent
ab
cd
occlusion better. Alternatively, consider refer­ral to a center with more expertise and experience.
2. Vessel perforation: Contrast extravasation outside the vein wall is usually asymptomatic if resulting from a wire perforation. It is the failure to recognize an extraluminal wire and subsequent balloon dilation that can have catastrophic consequences. Always conrm the wire position before proceeding with intervention. If extravasation persists, balloon tamponade, and reversal of anticoagulation usually seal the leak; however, covered stents should be readily available during all vascular procedures.
Tip: Bleeds from the IVC are usually well-
tamponaded in the retroperitoneum. Extra
care and caution should be taken in patients who have had prior surgical violation of their retroperitoneum in whom this protective effect may be lost. Likewise, patients with a history of radiation to the abdomen or pelvis may be at higher risk for vessel perforation or rupture.
3. Intraprocedural thrombosis: Adequate inow and outow across a vein is essential to maintain patency. Intraprocedural thrombo­sis may be a result of poor inow, outow, or inadequate anticoagulation. This can initially be treated with additional anticoagulation and pharmacomechanical thrombectomy. However, an exhaustive search for the etiol­ogy of the thrombosis is warranted with venography and IVUS.